US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ryder

243.13

-0.3500-0.14%

Volume:293.65K

Turnover:71.36M

Market Cap:9.32B

PE:19.73

High:244.51

Open:243.98

Low:241.50

Close:243.48

52wk High:284.25

52wk Low:157.67

Shares:38.35M

Float Shares:36.85M

Volume Ratio:1.30

T/O Rate:0.80%

Dividend:3.64

Dividend Rate:1.50%

EPS(TTM):12.33

EPS(LYR):11.94

ROE:16.70%

ROA:3.89%

PB:3.24

PE(LYR):20.37

Loading ...

Overview Company News Filings

Press Release: Tri Pointe Homes, Inc. Reports 2026 Second Quarter Results

Press Release: KULR Technology Group Reports Second Quarter 2026 Financial Results

Press Release: Cineverse Reports First Quarter Fiscal Year 2027 Results

Press Release: GrabAGun Digital Holdings Reports Second Quarter 2026 Results

Press Release: Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Press Release: Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Press Release: Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update

Press Release: CapsoVision Reports Second Quarter 2026 Financial Results

Press Release: Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: ARS Pharmaceuticals Outlines Strategic Priorities, Including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

Press Release: Nexon Releases Earnings for Second Quarter 2026

Press Release: Ideal Power Reports Second Quarter 2026 Financial Results

Press Release: Dogwood Therapeutics Announces Second Quarter 2026 Financial Results

Press Release: Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Press Release: Defsec Technologies Inc. Announces Third Quarter Fiscal 2026 Results

Press Release: McGraw Hill, Inc. Reports Strong Fiscal First Quarter 2027 Results Exceeding Expectations

Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/R/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"R","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","market":"US","secType":"STK","nameCN":"Ryder","latestPrice":243.13,"timestamp":1788379200000,"preClose":243.48,"halted":0,"volume":293649,"delay":0,"changeRate":-0.0014374897322161752,"floatShares":36853364,"shares":38346868,"eps":12.325055,"marketStatus":"Pre-Mkt","change":-0.35,"latestTime":"09-03 07:08:59 EDT","open":243.98,"high":244.51,"low":241.5,"amount":71356977.15708001,"amplitude":0.012362,"askPrice":244.83,"askSize":8,"bidPrice":240.95,"bidSize":8,"shortable":3,"etf":0,"ttmEps":12.325055,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-292968000000,"exchange":"NYSE","adjPreClose":243.13,"dividendRate":0.014971,"postHourTrading":{"tag":"盘后","latestPrice":243.13,"preClose":243.13,"latestTime":"19:30 EDT","volume":51409,"amount":12499070.17,"timestamp":1788391808945,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2963960380463522,"impliedVol":0.3036,"impliedVolPercentile":0.1275},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","floatShares":36853364,"roa":"3.89%","roe":"16.70%","lyrEps":11.937799,"volumeRatio":1.2963960380463522,"shares":38346868,"dividePrice":3.64,"high":244.51,"amplitude":0.012362,"preClose":243.48,"low":241.5,"week52Low":157.67,"pbRate":"3.24","psRate":"0.73","week52High":284.25,"institutionHeld":0.6454,"latestPrice":243.13,"eps":12.325055,"divideRate":0.014971,"volume":293649,"delay":0,"ttmEps":12.325055,"open":243.98,"prevYearClose":191.39,"prevWeekClose":245.86,"prevMonthClose":244.46,"prevQuarterClose":263.77,"fiveDayClose":249.64,"twentyDayClose":265.54,"sixtyDayClose":270.94,"dividendPayoutRate":0.28296082308697096,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.13157894736842102,"fiveYearAvgDividendRate":0.02341379230026732},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/R\",params:#limit:5,,,undefined,":[{"date":"2026-10-22","symbol":"R","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":4.16,"defaultRemindTime":1792656000000,"name":null,"time":"Pre-MKt","dateTimestamp":1792641600000,"actualEps":null},{"date":"2026-08-24","symbol":"R","amount":1.01,"announcedDate":"2026-07-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-24","defaultRemindTime":1787578200000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-08-24","currency":"USD","dateTimestamp":1787544000000,"payDate":"2026-09-18"},{"market":"US","date":"2026-07-23","symbol":"R","fiscalQuarterEnding":"2026/06","expectedEps":3.7,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1784779200000,"reportTimeType":"pre","actualEps":3.73},{"date":"2026-05-18","symbol":"R","amount":0.91,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-18","defaultRemindTime":1779111000000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-19","payableDate":"2026-05-18","currency":"USD","dateTimestamp":1779076800000,"payDate":"2026-06-19"},{"market":"US","date":"2026-04-23","symbol":"R","fiscalQuarterEnding":"2026/03","expectedEps":2.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1776916800000,"reportTimeType":"pre","actualEps":2.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"R\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-17","recordDate":"2016-11-21","paymentDate":"2016-12-16","value":0.44,"currency":"USD"},{"executeDate":"2017-02-16","recordDate":"2017-02-21","paymentDate":"2017-03-17","value":0.44,"currency":"USD"},{"executeDate":"2017-05-18","recordDate":"2017-05-22","paymentDate":"2017-06-16","value":0.44,"currency":"USD"},{"executeDate":"2017-08-17","recordDate":"2017-08-21","paymentDate":"2017-09-15","value":0.46,"currency":"USD"},{"executeDate":"2017-11-17","recordDate":"2017-11-20","paymentDate":"2017-12-15","value":0.46,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"R\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.5,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1784952000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/R\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"R","date":"2026-09-02","current":19.726484,"percent":0.936534,"low":4.335476,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"high":21.956761,"avg":11.386823,"sd":4.634594,"marketCap":9336695420},"quantilePoints":[{"date":"2021-09-03","current":16.395895,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4285755840},{"date":"2021-09-10","current":16.046171,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4194340722},{"date":"2021-09-17","current":16.161374,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4224453937},{"date":"2021-09-24","current":16.916367,"twenty":-7.751218,"median":9.87728,"eighty":16.7724,"marketCap":4421803045},{"date":"2021-10-01","current":17.126202,"twenty":-7.751218,"median":9.87728,"eighty":16.824146,"marketCap":4476652116},{"date":"2021-10-08","current":17.115916,"twenty":-7.751218,"median":9.87728,"eighty":16.86858,"marketCap":4473963436},{"date":"2021-10-15","current":17.229062,"twenty":-7.751218,"median":9.87728,"eighty":16.897726,"marketCap":4503538916},{"date":"2021-10-22","current":18.296749,"twenty":-7.751218,"median":9.87728,"eighty":16.957122,"marketCap":4782623895},{"date":"2021-10-29","current":12.544258,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4561242691},{"date":"2021-11-05","current":12.858787,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4675609342},{"date":"2021-11-12","current":12.99464,"twenty":-7.746632,"median":9.89274,"eighty":16.946201,"marketCap":4725007144},{"date":"2021-11-19","current":12.432031,"twenty":-7.746632,"median":9.89274,"eighty":16.881013,"marketCap":4520435811},{"date":"2021-11-26","current":12.601848,"twenty":-7.746632,"median":9.89274,"eighty":16.848905,"marketCap":4582183064},{"date":"2021-12-03","current":11.712896,"twenty":-7.746632,"median":9.89274,"eighty":16.823699,"marketCap":4258949621},{"date":"2021-12-10","current":11.980172,"twenty":-7.746632,"median":9.89274,"eighty":16.771738,"marketCap":4356134427},{"date":"2021-12-17","current":11.548987,"twenty":-7.746632,"median":9.89274,"eighty":16.734025,"marketCap":4199350099},{"date":"2021-12-23","current":11.717326,"twenty":-7.746632,"median":9.89274,"eighty":16.724457,"marketCap":4260560419},{"date":"2021-12-31","current":12.172139,"twenty":-7.746632,"median":9.89274,"eighty":16.688297,"marketCap":4425935669},{"date":"2022-01-07","current":11.528313,"twenty":-7.742047,"median":9.894559,"eighty":16.645088,"marketCap":4191833042},{"date":"2022-01-14","current":11.66269,"twenty":-7.742047,"median":9.894559,"eighty":16.569237,"marketCap":4240693911},{"date":"2022-01-21","current":11.074978,"twenty":-7.742047,"median":9.894559,"eighty":16.518713,"marketCap":4026994725},{"date":"2022-01-28","current":10.665942,"twenty":-7.742047,"median":9.894559,"eighty":16.390958,"marketCap":3878264386},{"date":"2022-02-04","current":10.595062,"twenty":-7.742047,"median":9.894559,"eighty":16.292436,"marketCap":3852491620},{"date":"2022-02-11","current":10.866768,"twenty":-7.742047,"median":9.894559,"eighty":16.266226,"marketCap":3951287224},{"date":"2022-02-18","current":8.156002,"twenty":-7.742047,"median":9.819077,"eighty":16.167134,"marketCap":4232965038},{"date":"2022-02-25","current":8.041976,"twenty":-7.742047,"median":9.683571,"eighty":16.061394,"marketCap":4173785303},{"date":"2022-03-04","current":8.192283,"twenty":-7.742047,"median":9.408015,"eighty":15.879949,"marketCap":4251794953},{"date":"2022-03-11","current":8.208869,"twenty":-7.742047,"median":8.965509,"eighty":15.706321,"marketCap":4260402915},{"date":"2022-03-18","current":8.2995,"twenty":-7.742047,"median":8.822833,"eighty":15.524465,"marketCap":4307440377},{"date":"2022-03-25","current":7.957709,"twenty":-7.742047,"median":8.777473,"eighty":15.400744,"marketCap":4130051128},{"date":"2022-04-01","current":7.287918,"twenty":-7.742047,"median":8.581191,"eighty":15.306166,"marketCap":3782429545},{"date":"2022-04-08","current":6.216252,"twenty":-7.742047,"median":8.486348,"eighty":15.123407,"marketCap":3226235013},{"date":"2022-04-14","current":6.305886,"twenty":-7.742047,"median":8.400577,"eighty":15.064281,"marketCap":3272754960},{"date":"2022-04-22","current":6.644722,"twenty":-7.742047,"median":8.337941,"eighty":15.019858,"marketCap":3448610584},{"date":"2022-04-29","current":5.552093,"twenty":-7.742047,"median":8.266103,"eighty":15.01151,"marketCap":3574453932},{"date":"2022-05-06","current":5.903169,"twenty":-7.742047,"median":8.228212,"eighty":15.01151,"marketCap":3800478057},{"date":"2022-05-13","current":6.644243,"twenty":-7.742047,"median":8.178807,"eighty":15.01151,"marketCap":4277583282},{"date":"2022-05-20","current":6.306669,"twenty":-7.742047,"median":8.111521,"eighty":15.01151,"marketCap":4060252392},{"date":"2022-05-27","current":6.362269,"twenty":-7.742047,"median":8.052823,"eighty":15.01151,"marketCap":4096048068},{"date":"2022-06-03","current":6.481413,"twenty":-7.742047,"median":8.032181,"eighty":15.01151,"marketCap":4172753088},{"date":"2022-06-10","current":6.150194,"twenty":-7.742047,"median":8.016693,"eighty":15.01151,"marketCap":3959513132},{"date":"2022-06-17","current":5.747488,"twenty":-7.742047,"median":7.956055,"eighty":15.01151,"marketCap":3700250164},{"date":"2022-06-24","current":5.650585,"twenty":-7.746632,"median":7.945333,"eighty":15.013418,"marketCap":3637863415},{"date":"2022-07-01","current":5.726042,"twenty":-7.746632,"median":7.897499,"eighty":15.013418,"marketCap":3686443261},{"date":"2022-07-08","current":5.746694,"twenty":-7.746632,"median":7.835691,"eighty":15.013418,"marketCap":3699738798},{"date":"2022-07-15","current":5.766551,"twenty":-7.746632,"median":7.772142,"eighty":15.013418,"marketCap":3712522968},{"date":"2022-07-22","current":5.926204,"twenty":-7.746632,"median":7.442255,"eighty":15.013418,"marketCap":3815307694},{"date":"2022-07-29","current":5.461894,"twenty":-7.746632,"median":6.699881,"eighty":15.013418,"marketCap":4009565771},{"date":"2022-08-05","current":5.457013,"twenty":-7.746632,"median":6.644722,"eighty":15.013418,"marketCap":4005982145},{"date":"2022-08-12","current":5.788269,"twenty":-7.746632,"median":6.481413,"eighty":15.013418,"marketCap":4249156780},{"date":"2022-08-19","current":5.654372,"twenty":-7.746632,"median":6.388625,"eighty":15.013418,"marketCap":4150863032},{"date":"2022-08-26","current":5.604858,"twenty":-7.746632,"median":6.320172,"eighty":15.013418,"marketCap":4114514824},{"date":"2022-09-02","current":5.186429,"twenty":-7.746632,"median":6.234388,"eighty":15.013418,"marketCap":3807346864},{"date":"2022-09-09","current":5.427723,"twenty":-7.746632,"median":6.204433,"eighty":15.013418,"marketCap":3984480387},{"date":"2022-09-16","current":4.997438,"twenty":-7.746632,"median":6.039787,"eighty":15.013418,"marketCap":3668609335},{"date":"2022-09-23","current":4.66409,"twenty":-7.746632,"median":5.934147,"eighty":15.013418,"marketCap":3423898860},{"date":"2022-09-30","current":5.264535,"twenty":-7.746632,"median":5.891255,"eighty":14.984817,"marketCap":3864684883},{"date":"2022-10-07","current":5.515593,"twenty":-7.746632,"median":5.79038,"eighty":14.962577,"marketCap":4048985659},{"date":"2022-10-14","current":5.330787,"twenty":-7.746632,"median":5.747488,"eighty":14.951585,"marketCap":3913319810},{"date":"2022-10-21","current":5.177363,"twenty":-7.746632,"median":5.716511,"eighty":14.921021,"marketCap":3800691558},{"date":"2022-10-28","current":4.875682,"twenty":-7.746632,"median":5.696654,"eighty":14.896597,"marketCap":4105514216},{"date":"2022-11-04","current":4.97415,"twenty":-7.746632,"median":5.677591,"eighty":14.776301,"marketCap":4188428518},{"date":"2022-11-11","current":5.292233,"twenty":-7.746632,"median":5.663293,"eighty":14.711779,"marketCap":4456266838},{"date":"2022-11-18","current":5.380557,"twenty":-7.746632,"median":5.641848,"eighty":14.711779,"marketCap":4530638454},{"date":"2022-11-25","current":5.732059,"twenty":-7.746632,"median":5.632098,"eighty":14.711779,"marketCap":4826617386},{"date":"2022-12-02","current":5.390702,"twenty":-7.746632,"median":5.616713,"eighty":13.024764,"marketCap":4539181140},{"date":"2022-12-09","current":5.00757,"twenty":-7.746632,"median":5.60073,"eighty":12.852585,"marketCap":4216569129},{"date":"2022-12-16","current":5.043377,"twenty":-7.746632,"median":5.579284,"eighty":12.794995,"marketCap":4246719784},{"date":"2022-12-23","current":5.054119,"twenty":-7.746632,"median":5.556738,"eighty":12.683064,"marketCap":4255764981},{"date":"2022-12-30","current":4.987279,"twenty":-7.746632,"median":5.542093,"eighty":12.55727,"marketCap":4199483758},{"date":"2023-01-06","current":4.977134,"twenty":-7.746632,"median":5.530238,"eighty":12.411068,"marketCap":4190941072},{"date":"2023-01-13","current":5.452767,"twenty":-7.746632,"median":5.515593,"eighty":12.297336,"marketCap":4591442276},{"date":"2023-01-20","current":5.542284,"twenty":-7.746632,"median":5.512803,"eighty":12.262396,"marketCap":4666818914},{"date":"2023-01-27","current":5.635978,"twenty":-7.746632,"median":5.512803,"eighty":12.179012,"marketCap":4745713128},{"date":"2023-02-03","current":5.849625,"twenty":-7.746632,"median":5.504687,"eighty":12.076451,"marketCap":4925612037},{"date":"2023-02-10","current":5.754737,"twenty":-7.746632,"median":5.504687,"eighty":12.026911,"marketCap":4845712801},{"date":"2023-02-17","current":5.263255,"twenty":-7.746632,"median":5.498719,"eighty":11.969767,"marketCap":4563242372},{"date":"2023-02-24","current":5.148999,"twenty":-7.746632,"median":5.492154,"eighty":11.969767,"marketCap":4464182332},{"date":"2023-03-03","current":5.301697,"twenty":-7.746632,"median":5.485925,"eighty":11.969767,"marketCap":4596570983},{"date":"2023-03-10","current":4.857486,"twenty":-7.746632,"median":5.474851,"eighty":11.969767,"marketCap":4211440363},{"date":"2023-03-17","current":4.455455,"twenty":-7.746632,"median":5.452767,"eighty":11.969767,"marketCap":3862879398},{"date":"2023-03-24","current":4.499409,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3900987688},{"date":"2023-03-31","current":4.783503,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":4147297371},{"date":"2023-04-06","current":4.522458,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":3920971304},{"date":"2023-04-14","current":4.579277,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3970233240},{"date":"2023-04-21","current":4.639312,"twenty":-7.746632,"median":5.394248,"eighty":11.969767,"marketCap":4022283588},{"date":"2023-04-28","current":4.360113,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3618893391},{"date":"2023-05-05","current":4.456979,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3699292590},{"date":"2023-05-12","current":4.543916,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771449940},{"date":"2023-05-19","current":4.544476,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771914863},{"date":"2023-05-26","current":4.48342,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3721238329},{"date":"2023-06-02","current":4.478378,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3717054028},{"date":"2023-06-09","current":4.659306,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3867223940},{"date":"2023-06-16","current":4.628498,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3841653212},{"date":"2023-06-23","current":4.605532,"twenty":-7.751218,"median":5.393551,"eighty":11.973235,"marketCap":3822591397},{"date":"2023-06-30","current":4.710279,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3909531872},{"date":"2023-07-07","current":4.670509,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3876522387},{"date":"2023-07-14","current":4.972428,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4127115523},{"date":"2023-07-21","current":5.1696,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4290768183},{"date":"2023-07-28","current":7.905694,"twenty":-7.755803,"median":5.397863,"eighty":11.976704,"marketCap":4529962569},{"date":"2023-08-04","current":7.943832,"twenty":-7.755803,"median":5.452767,"eighty":11.976704,"marketCap":4551815654},{"date":"2023-08-11","current":8.064602,"twenty":-7.755803,"median":5.493974,"eighty":11.976704,"marketCap":4621017093},{"date":"2023-08-18","current":7.684017,"twenty":-7.755803,"median":5.519009,"eighty":11.976704,"marketCap":4402941508},{"date":"2023-08-25","current":7.629988,"twenty":-7.755803,"median":5.540699,"eighty":11.976704,"marketCap":4371982969},{"date":"2023-09-01","current":8.001039,"twenty":-7.755803,"median":5.556738,"eighty":11.976704,"marketCap":4584595283},{"date":"2023-09-08","current":7.796047,"twenty":-7.755803,"median":5.572744,"eighty":11.976704,"marketCap":4467134947},{"date":"2023-09-15","current":8.072548,"twenty":-7.755803,"median":5.598162,"eighty":11.976704,"marketCap":4625569819},{"date":"2023-09-22","current":8.255292,"twenty":-7.755803,"median":5.622292,"eighty":11.976704,"marketCap":4730282521},{"date":"2023-09-29","current":8.464257,"twenty":-7.755803,"median":5.641349,"eighty":11.976704,"marketCap":4850019220},{"date":"2023-10-06","current":7.874707,"twenty":-7.755803,"median":5.654372,"eighty":11.976704,"marketCap":4512206936},{"date":"2023-10-13","current":8.166304,"twenty":-7.755803,"median":5.677385,"eighty":11.976704,"marketCap":4679291988},{"date":"2023-10-20","current":7.969257,"twenty":-7.755803,"median":5.687122,"eighty":11.976704,"marketCap":4566384378},{"date":"2023-10-27","current":8.466638,"twenty":-7.81017,"median":5.70583,"eighty":11.984307,"marketCap":4131719492},{"date":"2023-11-03","current":8.900778,"twenty":-7.81017,"median":5.736104,"eighty":11.984307,"marketCap":4343579814},{"date":"2023-11-10","current":9.098775,"twenty":-7.81017,"median":5.748824,"eighty":11.984307,"marketCap":4440202303},{"date":"2023-11-17","current":9.541998,"twenty":-7.81017,"median":5.774024,"eighty":11.984307,"marketCap":4656494849},{"date":"2023-11-24","current":9.76815,"twenty":-7.81017,"median":5.792649,"eighty":11.984307,"marketCap":4766857234},{"date":"2023-12-01","current":9.730912,"twenty":-7.81017,"median":5.832915,"eighty":11.984307,"marketCap":4748685115},{"date":"2023-12-08","current":9.643721,"twenty":-7.785279,"median":5.902141,"eighty":11.982239,"marketCap":4706135761},{"date":"2023-12-15","current":10.11964,"twenty":-7.785279,"median":5.934147,"eighty":11.982239,"marketCap":4938384315},{"date":"2023-12-22","current":10.650962,"twenty":-7.785279,"median":6.039787,"eighty":11.982239,"marketCap":5197669436},{"date":"2023-12-29","current":10.469313,"twenty":-7.81017,"median":6.186334,"eighty":11.984307,"marketCap":5109024950},{"date":"2024-01-05","current":10.161419,"twenty":-7.835061,"median":6.212148,"eighty":11.986374,"marketCap":4958772546},{"date":"2024-01-12","current":10.035173,"twenty":-7.835061,"median":6.306669,"eighty":11.986374,"marketCap":4897164629},{"date":"2024-01-19","current":10.137805,"twenty":-7.859952,"median":6.350752,"eighty":11.988442,"marketCap":4947248763},{"date":"2024-01-26","current":10.437525,"twenty":-7.835061,"median":6.413898,"eighty":11.986374,"marketCap":5093512165},{"date":"2024-02-02","current":10.526533,"twenty":-7.835061,"median":6.548928,"eighty":11.986374,"marketCap":5136947963},{"date":"2024-02-09","current":10.603733,"twenty":-7.835061,"median":6.662452,"eighty":11.986374,"marketCap":5174621870},{"date":"2024-02-16","current":11.958272,"twenty":-7.835061,"median":6.699881,"eighty":11.992994,"marketCap":4855058498},{"date":"2024-02-23","current":12.181128,"twenty":-7.835061,"median":6.699881,"eighty":12.003352,"marketCap":4945538144},{"date":"2024-03-01","current":12.341207,"twenty":-7.81017,"median":6.732825,"eighty":12.070758,"marketCap":5010530121},{"date":"2024-03-08","current":12.549959,"twenty":-7.81017,"median":6.732825,"eighty":12.1283,"marketCap":5095283172},{"date":"2024-03-15","current":12.315273,"twenty":-7.81017,"median":6.732825,"eighty":12.192966,"marketCap":5000001022},{"date":"2024-03-22","current":12.709973,"twenty":-7.81017,"median":6.732825,"eighty":12.252055,"marketCap":5160248952},{"date":"2024-03-28","current":12.9324,"twenty":-7.81017,"median":6.732825,"eighty":12.27243,"marketCap":5250554416},{"date":"2024-04-05","current":12.824457,"twenty":-7.835061,"median":6.699881,"eighty":12.310529,"marketCap":5206729706},{"date":"2024-04-12","current":12.753586,"twenty":-7.835061,"median":6.699881,"eighty":12.337386,"marketCap":5177955906},{"date":"2024-04-19","current":11.685063,"twenty":-7.835061,"median":6.699881,"eighty":12.340342,"marketCap":4744135543},{"date":"2024-04-26","current":15.244202,"twenty":-7.81017,"median":6.732825,"eighty":12.359817,"marketCap":5365959126},{"date":"2024-05-03","current":15.528093,"twenty":-7.81017,"median":6.732825,"eighty":12.422817,"marketCap":5465888775},{"date":"2024-05-10","current":15.863035,"twenty":-7.81017,"median":6.732825,"eighty":12.516984,"marketCap":5583788228},{"date":"2024-05-17","current":15.561712,"twenty":-7.81017,"median":6.732825,"eighty":12.565399,"marketCap":5477722549},{"date":"2024-05-24","current":14.992685,"twenty":-7.81017,"median":6.732825,"eighty":12.683064,"marketCap":5277424965},{"date":"2024-05-31","current":15.007626,"twenty":-7.81017,"median":6.732825,"eighty":12.75491,"marketCap":5282684420},{"date":"2024-06-07","current":14.981478,"twenty":-7.81017,"median":6.732825,"eighty":12.826376,"marketCap":5273480373},{"date":"2024-06-14","current":14.965292,"twenty":-7.835061,"median":6.699881,"eighty":12.854653,"marketCap":5267782630},{"date":"2024-06-21","current":15.053696,"twenty":-7.859952,"median":6.696926,"eighty":12.903973,"marketCap":5298901073},{"date":"2024-06-28","current":15.257899,"twenty":-7.926764,"median":6.670331,"eighty":12.934444,"marketCap":5370780294},{"date":"2024-07-05","current":15.332607,"twenty":-7.926764,"median":6.670331,"eighty":13.078605,"marketCap":5397077570},{"date":"2024-07-12","current":15.560467,"twenty":-7.926764,"median":6.670331,"eighty":14.67393,"marketCap":5477284261},{"date":"2024-07-15","current":16.031128,"twenty":-7.926764,"median":6.670331,"eighty":14.798941,"marketCap":5642957098},{"date":"2024-08-02","current":12.046137,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986929872},{"date":"2024-08-09","current":11.643786,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5786961567},{"date":"2024-08-16","current":11.960789,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5944512353},{"date":"2024-08-23","current":12.044395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986064208},{"date":"2024-08-30","current":12.267342,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6096869157},{"date":"2024-09-06","current":11.844961,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5886945719},{"date":"2024-09-13","current":11.837994,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5883483065},{"date":"2024-09-20","current":12.877836,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6400284270},{"date":"2024-09-27","current":12.605247,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6264807907},{"date":"2024-10-04","current":12.39275,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6159196940},{"date":"2024-10-11","current":12.762878,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6343150468},{"date":"2024-10-18","current":12.754684,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6339078000},{"date":"2024-10-25","current":12.285395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5872418977},{"date":"2024-10-31","current":13.170128,"twenty":-8.0879,"median":6.543636,"eighty":14.807159,"marketCap":6295321107},{"date":"2024-11-08","current":14.050437,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6716108726},{"date":"2024-11-15","current":14.657363,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7006219587},{"date":"2024-11-22","current":14.262772,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6817605237},{"date":"2024-11-29","current":14.937823,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7140279562},{"date":"2024-12-06","current":14.566236,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6962660668},{"date":"2024-12-13","current":14.75026,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7050624311},{"date":"2024-12-20","current":13.771746,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6582894555},{"date":"2024-12-27","current":14.153066,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6765165373},{"date":"2025-01-03","current":13.844294,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6617572530},{"date":"2025-01-10","current":14.016817,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6700038445},{"date":"2025-01-17","current":14.647631,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7001567664},{"date":"2025-01-24","current":14.644977,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7000298957},{"date":"2025-01-31","current":14.36894,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6868353493},{"date":"2025-02-07","current":13.879683,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6634488615},{"date":"2025-02-14","current":13.862207,"twenty":-8.03386,"median":6.543636,"eighty":13.316137,"marketCap":6778619352},{"date":"2025-02-21","current":14.292524,"twenty":-7.746632,"median":6.652028,"eighty":13.787317,"marketCap":6989043992},{"date":"2025-02-28","current":13.739137,"twenty":-7.30351,"median":6.732825,"eighty":13.829167,"marketCap":6718437905},{"date":"2025-03-07","current":13.320009,"twenty":-6.938007,"median":7.55689,"eighty":13.830759,"marketCap":6513484306},{"date":"2025-03-14","current":11.737306,"twenty":-6.885604,"median":7.691962,"eighty":13.830759,"marketCap":5739542480},{"date":"2025-03-21","current":11.989848,"twenty":-6.794229,"median":7.780156,"eighty":13.830759,"marketCap":5863035670},{"date":"2025-03-28","current":12.289466,"twenty":-6.704491,"median":7.818294,"eighty":13.830759,"marketCap":6009548949},{"date":"2025-04-04","current":11.830222,"twenty":-6.612788,"median":7.905144,"eighty":13.830759,"marketCap":5784978738},{"date":"2025-04-11","current":11.83449,"twenty":-6.460167,"median":7.944627,"eighty":13.830628,"marketCap":5787065822},{"date":"2025-04-17","current":11.790103,"twenty":-6.392044,"median":7.965682,"eighty":13.830628,"marketCap":5765360151},{"date":"2025-04-25","current":11.457658,"twenty":-6.145958,"median":8.001039,"eighty":13.830759,"marketCap":5751744390},{"date":"2025-05-02","current":11.438717,"twenty":-5.907983,"median":8.021733,"eighty":13.830759,"marketCap":5742236008},{"date":"2025-05-09","current":12.069535,"twenty":4.422322,"median":8.052268,"eighty":13.830759,"marketCap":6058906475},{"date":"2025-05-16","current":12.972115,"twenty":4.465495,"median":8.071753,"eighty":13.830759,"marketCap":6512001555},{"date":"2025-05-23","current":12.379179,"twenty":4.482002,"median":8.092411,"eighty":13.830759,"marketCap":6214347853},{"date":"2025-05-30","current":12.411296,"twenty":4.504369,"median":8.124987,"eighty":13.830759,"marketCap":6230470762},{"date":"2025-06-06","current":12.205416,"twenty":4.52924,"median":8.150819,"eighty":13.830759,"marketCap":6127118782},{"date":"2025-06-13","current":12.324003,"twenty":4.54414,"median":8.183784,"eighty":13.830759,"marketCap":6186649522},{"date":"2025-06-20","current":12.475531,"twenty":4.557695,"median":8.223114,"eighty":13.830891,"marketCap":6262716580},{"date":"2025-06-27","current":13.078349,"twenty":4.57381,"median":8.253849,"eighty":13.830891,"marketCap":6565331177},{"date":"2025-07-03","current":14.129163,"twenty":4.586262,"median":8.30557,"eighty":13.858624,"marketCap":7092839683},{"date":"2025-07-11","current":14.494806,"twenty":4.600504,"median":8.337941,"eighty":13.890852,"marketCap":7276392799},{"date":"2025-07-18","current":14.164574,"twenty":4.608827,"median":8.434859,"eighty":13.981782,"marketCap":7110616224},{"date":"2025-07-25","current":14.307417,"twenty":4.625011,"median":8.858999,"eighty":14.002789,"marketCap":7225245354},{"date":"2025-08-01","current":14.354265,"twenty":4.633104,"median":9.160989,"eighty":14.049906,"marketCap":7248903923},{"date":"2025-08-08","current":14.19918,"twenty":4.650193,"median":9.572878,"eighty":14.097858,"marketCap":7170585902},{"date":"2025-08-15","current":14.709669,"twenty":4.666003,"median":9.666427,"eighty":14.127845,"marketCap":7428382721},{"date":"2025-08-22","current":14.573161,"twenty":4.709831,"median":9.71638,"eighty":14.151964,"marketCap":7359446547},{"date":"2025-08-29","current":15.114344,"twenty":4.783503,"median":9.76815,"eighty":14.198571,"marketCap":7632743808},{"date":"2025-09-05","current":15.23712,"twenty":4.812786,"median":9.833544,"eighty":14.238885,"marketCap":7694745575},{"date":"2025-09-12","current":15.312239,"twenty":4.861125,"median":10.041985,"eighty":14.314092,"marketCap":7732680866},{"date":"2025-09-19","current":14.993992,"twenty":4.931659,"median":10.156878,"eighty":14.354103,"marketCap":7571965760},{"date":"2025-09-26","current":14.909987,"twenty":4.960305,"median":10.2309,"eighty":14.420027,"marketCap":7529543499},{"date":"2025-10-03","current":15.384936,"twenty":4.977731,"median":10.32899,"eighty":14.468748,"marketCap":7769392438},{"date":"2025-10-10","current":14.883332,"twenty":4.997531,"median":10.44025,"eighty":14.503112,"marketCap":7516082589},{"date":"2025-10-17","current":14.752479,"twenty":5.035793,"median":10.493382,"eighty":14.525335,"marketCap":7450001759},{"date":"2025-10-24","current":12.89259,"twenty":5.054716,"median":10.599398,"eighty":14.539205,"marketCap":6472080000},{"date":"2025-10-31","current":13.625069,"twenty":5.097183,"median":10.658452,"eighty":14.539205,"marketCap":6839784859},{"date":"2025-11-07","current":13.479489,"twenty":5.12209,"median":10.73345,"eighty":14.539205,"marketCap":6766703333},{"date":"2025-11-14","current":13.617026,"twenty":5.133219,"median":10.893348,"eighty":14.539205,"marketCap":6835747206},{"date":"2025-11-21","current":13.070093,"twenty":5.152815,"median":11.090483,"eighty":14.539205,"marketCap":6561186775},{"date":"2025-11-28","current":13.873602,"twenty":5.177781,"median":11.196803,"eighty":14.539205,"marketCap":6964548349},{"date":"2025-12-05","current":14.478446,"twenty":5.19145,"median":11.302112,"eighty":14.539205,"marketCap":7268179885},{"date":"2025-12-12","current":15.927014,"twenty":5.207168,"median":11.404144,"eighty":14.629582,"marketCap":7995361262},{"date":"2025-12-19","current":15.296433,"twenty":5.254517,"median":11.451225,"eighty":14.655417,"marketCap":7678809236},{"date":"2025-12-26","current":15.906907,"twenty":5.265027,"median":11.491086,"eighty":14.698585,"marketCap":7985267129},{"date":"2026-01-02","current":15.393755,"twenty":5.303504,"median":11.530528,"eighty":14.710447,"marketCap":7727664842},{"date":"2026-01-09","current":15.285172,"twenty":5.326043,"median":11.631919,"eighty":14.756356,"marketCap":7673156521},{"date":"2026-01-16","current":15.624593,"twenty":5.335095,"median":11.673876,"eighty":14.821626,"marketCap":7843545494},{"date":"2026-01-23","current":15.790281,"twenty":5.381631,"median":11.714373,"eighty":14.842245,"marketCap":7926721154},{"date":"2026-01-30","current":15.476599,"twenty":5.397735,"median":11.740952,"eighty":14.909825,"marketCap":7769252672},{"date":"2026-02-06","current":17.236437,"twenty":5.43372,"median":11.783021,"eighty":14.940109,"marketCap":8652691236},{"date":"2026-02-13","current":16.435376,"twenty":5.467946,"median":11.830222,"eighty":14.977245,"marketCap":8201252704},{"date":"2026-02-20","current":17.329797,"twenty":5.50631,"median":11.845396,"eighty":14.992461,"marketCap":8647568653},{"date":"2026-02-27","current":17.630044,"twenty":5.529122,"median":11.868324,"eighty":15.006515,"marketCap":8797392028},{"date":"2026-03-06","current":16.622636,"twenty":5.543836,"median":11.926274,"eighty":15.027061,"marketCap":8294695177},{"date":"2026-03-13","current":14.692322,"twenty":5.566305,"median":11.961621,"eighty":15.051953,"marketCap":7331468705},{"date":"2026-03-20","current":15.122092,"twenty":5.582426,"median":12.000539,"eighty":15.06114,"marketCap":7545923966},{"date":"2026-03-27","current":15.704285,"twenty":5.607776,"median":12.030258,"eighty":15.075828,"marketCap":7836438314},{"date":"2026-04-02","current":16.252694,"twenty":5.634545,"median":12.044612,"eighty":15.114182,"marketCap":8110094204},{"date":"2026-04-10","current":17.445365,"twenty":5.643595,"median":12.073512,"eighty":15.122356,"marketCap":8705236958},{"date":"2026-04-17","current":17.393509,"twenty":5.667538,"median":12.105673,"eighty":15.140077,"marketCap":8679361186},{"date":"2026-04-24","current":19.000109,"twenty":5.68188,"median":12.153841,"eighty":15.16364,"marketCap":9386054056},{"date":"2026-05-01","current":19.875748,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9818619637},{"date":"2026-05-08","current":18.939802,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9356261972},{"date":"2026-05-15","current":18.097058,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":8939946619},{"date":"2026-05-22","current":18.675857,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9225873242},{"date":"2026-05-29","current":19.487272,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":9626712188},{"date":"2026-06-05","current":20.75217,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10251572129},{"date":"2026-06-12","current":21.956761,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10846639986},{"date":"2026-06-18","current":20.841457,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10295679889},{"date":"2026-06-26","current":20.984003,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10366097542},{"date":"2026-07-02","current":20.833625,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10291810788},{"date":"2026-07-10","current":21.117934,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10432259183},{"date":"2026-07-17","current":21.386578,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10564969375},{"date":"2026-07-24","current":20.671045,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10273509405},{"date":"2026-07-31","current":19.919539,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":9900010911},{"date":"2026-08-07","current":20.237425,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10058000007},{"date":"2026-08-14","current":20.305322,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10091745251},{"date":"2026-08-21","current":19.123282,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9504271233},{"date":"2026-08-28","current":19.1418,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9513474482},{"date":"2026-09-02","current":18.786107,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9336695420}],"updateTime":1788431466562},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"R\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659673211","title":"Press Release: Tri Pointe Homes, Inc. Reports 2026 Second Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673211?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"INCLINE VILLAGE, Nev., Aug. 13, 2026  -- Tri Pointe Homes, Inc.  today announced results for the second quarter ended June 30, 2026.Results and Operational Data for Second Quarter 2026 and Comparisons to Second Quarter 2025-- Home sales revenue of $685.1 million compared to $879.8 million. -- New home deliveries of 1,013 homes compared to 1,326 homes. -- Average sales price of homes delivered of $676,000 compared to. -- Homebuilding gross margin percentage of 18.0% compared to 20.8%.Excluding inventory-related charges of $19.7 million, our homebuilding. -- Excluding interest and impairments and lot option abandonments,-- SG&A expense as a percentage of home sales revenue of 32.5% compared to. -- Loss before income taxes was $165.3 million compared to income before. of availability under our revolving credit facility*  See \"Reconciliation of Non-GAAP Financial Measures\"About Tri Pointe Homes, Inc.One of the largest homebuilders in the U.S., Tri Pointe Homes, Inc. has a presence in 13 st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","TM","CFA.SI","BK4604","BK4588","CLR.SI","SRT.SI","BK4232","BK4022","BK4585","GLS.SI","BK4555","SRU.SI","JJJ.SI","R","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659333167","title":"Press Release: KULR Technology Group Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659333167","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659333167?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"HOUSTON, Aug. 13, 2026 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the \"Company\" or \"KULR\"), a developer of safe, high-power energy systems that enable physical AI across sp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4096","BK4232","BK4022","R","KULR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167850","title":"Press Release: Cineverse Reports First Quarter Fiscal Year 2027 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167850","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167850?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:13","pubTimestamp":1786651980,"startTime":"0","endTime":"0","summary":"-- First Quarter Revenue of $30.6 Million, a $19.5 Million or 175% Increase. -- More Than 60% of Total Revenues Were Technology Related. -- Adjusted EBITDA of $0.5 Million, a $2.6 Million Increase Over the Prior. -- Cash Flow From Operations Increased $13 Million Over the Prior Year. -- Building on $2.0 Million of Savings Achieved in Fiscal 2026, Company. Reaffirms Its Fiscal 2027 Cost Savings Target of $8.0 Million, with More. Than $3 Million Achieved to Date in Q2.-- Including the Company's Synergy Program, Annual Target Upside is $13. -- Most-Watched Streaming Quarter in Company History: 4.5 Billion. -- Company Reaffirms Full Year Fiscal 2027 Guidance of $115 to $120 Million. fiscal 2026 fourth quarter revenue by $8.0 million.-- During the first quarter, the Company successfully. Matchpoint. As a result, the Company realized an estimated. consistent with the prior year. Notably, this quarter had no wide film. releases, in comparison to last year which had Terrifier 3, the best. perf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4108","BK4232","BK4022","CNVS","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659673951","title":"Press Release: GrabAGun Digital Holdings Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673951","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673951?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:12","pubTimestamp":1786651920,"startTime":"0","endTime":"0","summary":"Second Quarter Revenues Increased 9.4% Year-Over-Year to $23.2 Million; Firearms Sales Increased 8.5% for the Same PeriodSecond Quarter Gross Profit Increased 39.4% and Gross Margin Expanded 290 Basis","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","PEW","R","BK4022","BK4200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162466","title":"Press Release: Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162466","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162466?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:06","pubTimestamp":1786651560,"startTime":"0","endTime":"0","summary":"-- REVTORPYK  approved by the U.S. FDA for the treatment of. HR+/HER2- PIK3CA Wild-Type locally advanced or metastatic breast cancer. on July 14, 2026; on track for commercial launch late third quarter 2026. -- NCCN Clinical Practice Guidelines recommended REVTORPYK in combination. with fulvestrant, with or without palbociclib, as a preferred Category 1. option for second-line therapy in HR+/HER2- advanced breast cancer. -- The Phase 3 PIK3CA mutant cohort of the VIKTORIA-1 trial achieved its. primary endpoint by doubling the likelihood of survival without disease. progression or death compared to alpelisib plus fulvestrant; a. supplemental New Drug Application  is planned for submission in","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4604","BK4232","BK4099","03160","BK4588","CELC","BK4139","BK4022","TM","R","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659629201","title":"Press Release: Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659629201","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659629201?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"All participants successfully dosed in SLIM-1(TM), the Company's first-in-human Phase 1 trial of NPM-139, a miniature, ultra long-acting semaglutide implant for chronic weight management; top-line dat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","TM","BK4232","BK4082","03160","BK4099","BK4604","BK4588","CRGT","R","VANI","BK4585","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659216257","title":"Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659216257","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659216257?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quarter of 2025Partnered programs continue to advance with Crystalys Therapeutics announcing its $130 mil","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4588","FBIO","TM","BK4581","XBI","DERM","BK4022","BK4139","BK4604","BK4099","BK4555","HELS","R","BK4007","BK4232","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162993","title":"Press Release: Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162993","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162993?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"-- Achieved Q2 2026 PEMGARDA  net product revenue of $14.3. million, representing 21% growth versus Q2 2025 net product revenue of. -- Completed rapid enrollment in VYD2311 DECLARATION clinical trial. expansion cohort and LIBERTY clinical trial, driven by strong subject. -- DECLARATION pivotal clinical trial enrollment is complete; the ongoing. study is approaching its planned analysis, and in lieu of a Q2 2026. quarterly earnings call, Invivyd plans to hold an investor call post. -- Strong balance sheet with Q2 2026 ending cash and cash equivalents of. $160.1 million anticipated to provide runway through DECLARATION pivotal. data readout and support potential commercial launch readiness for. 30, 2026, compared to $11.8 million in for the quarter ended June 30,-- In July 2026, Invivyd announced receipt of twelve months' advanced notice. of emergency use authorization  termination for PEMGARDA and that. the company is in dialogue with the U.S. Food and Drug Administration.  about approp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","IDNA","HYLG","BK4232","BNTX","BK4535","BK4585","R","BK4022","BK4139","BK4551","BK4539","BK4548","IND","BK4588","BK4568","MEDX","NVIB","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162161","title":"Press Release: Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162161","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162161?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"the second quarter of 2026, representing approximately 71% growth. compared to first quarter 2026 revenue of $3.5 million.--  Bottles Dispensed: Dispensed 8,294 bottles during Q2 2026, compared. with 6,054 in Q1 2026, representing approximately 37%. the quarter to 2,997 in June, reflecting consistent commercial momentum.--  Expanding Prescriber Base: Q2 2026 prescribing healthcare professionals. increased to 1,347, compared with 1,060 in Q1 2026, representing. professionals reached 1,908 launch-to-date, compared with 1,484 at March. 31, 2026, reflecting continued expansion of the Company's prescriber. --  Repeat Prescribers: Repeat prescribers increased to 1,024, compared. with 795 in Q1 2026, representing 29% sequential growth. Approximately","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","ACOG","BK4139","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162134","title":"Press Release: CapsoVision Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162134?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"SARATOGA, Calif., Aug. 13, 2026  -- CapsoVision, Inc. , a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results and provided a business update for its second quarter ended June 30, 2026.Recent Highlights-- Reported second quarter 2026 revenue was $3.6 million, up 10% year over. -- CapsoCam Plus used by over 176,000 patients as of June 30, 2026.-- Launched AI Highlights, the AI-assisted reading feature for CapsoCam. Plus, commercially in the European Union and other international. markets to support physician review of small bowel capsule endoscopy. -- Anticipate FDA clearance of AI Highlights by the end of the third. quarter of 2026, with U.S. commercial launch expected shortly thereafter.-- Continued commercial momentum with expanding adoption across large. hospital systems and GI networks, including key customer renewals and. -- Pipeline continues to advance with CapsoCam Colon on track for","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","03160","BK4604","QTOC","R","BK4099","AIPO","CV","BK4022","AGIX","ARTY","BK4232","BK4585","CHAT","BK4082","BK4555","BK4588","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659683162","title":"Press Release: Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659683162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659683162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651320,"startTime":"0","endTime":"0","summary":"-- Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody. prostate cancer , continues enrolling with interim analysis on. -- Phase 3 protocol of roxadustat for the treatment of anemia in patients. burden  has been finalized with the goal to initiate the. -- Additional data from the Phase 3 MATTERHORN study were presented at the. improvements in transfusion independence in patients with HTB and. -- Cash, cash equivalents, investments, and accounts receivable of $95.7. -- Kyntra Bio to host conference call and webcast presentation today at 5:00. first-in-class ADC targeting CD46 in mCRPC continues; interim analysis is. on track for the fourth quarter of 2026.Roxadustat-- Pivotal Phase 3 trial protocol of roxadustat for the treatment of anemia. in patients with LR-MDS and high transfusion burden  has been. -- In a post hoc analysis of the Phase 3 MATTERHORN study, patients. treated with roxadustat showed a clinically meaningful improvement. in transfusion independence ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4206","ADC","BK4109","03160","LU0128525689.USD","LU1267930227.SGD","BK4232","BK4022","BK4231","KYNB","LU0211327993.USD","BK4555","BK4588","BK4080","TM","BK4604","BK4099","LU0310800965.SGD","LU0052756011.USD","LU2236285917.USD","LU1267930490.SGD","NETL","HTB","LU0310799852.SGD","BK4585","LU0211328371.USD","DD","R","BK4139","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659032164","title":"Press Release: ARS Pharmaceuticals Outlines Strategic Priorities, Including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659032164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659032164?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651260,"startTime":"0","endTime":"0","summary":"broad consumer-directed marketing to targeted engagement with high-volume. prescribers, a strategy that has already demonstrated to grow","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","BK4232","SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169948","title":"Press Release: Nexon Releases Earnings for Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169948","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169948?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:19","pubTimestamp":1786641540,"startTime":"0","endTime":"0","summary":"sustained growth of the MapleStory franchise and a solid contribution. from ARC Raiders -- up 2% year over year on an as-reported basis or. --  Operating income was above our outlook at Yen31.3 billion, down 17%. year over year on an as-reported basis or down 31% on a constant-currency. basis5, reflecting a shift in our product mix with higher revenue-linked. costs -- including creator fees, user-acquisition  costs, plus cloud. service fees from growing global live services and data usage, along with. --  Relative to our outlook, total expenses were below our plan, as higher. creator fees were more than offset by lower-than-planned HR costs on a. non-recurring reversal of share-based compensation, and lower royalties. --  Net income6 exceeded our outlook at Yen29.6 billion, driven by the. operating income outperformance and a Yen5.5 billion valuation gain on. funds. Year over year, it was up 77% primarily due to a Yen1.7 billion FX. loss in Q2 2026 compared to a Yen17.5 billion loss re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","BK4209","PC","R","RPG","BK4202","BK4585","UA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157776","title":"Press Release: Ideal Power Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157776","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157776?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:20","pubTimestamp":1786627200,"startTime":"0","endTime":"0","summary":"are in the process of finalizing low current SSCB prototype units for. shipment to the customer later this month for their internal testing.B-TRAN-enabled SSCB prototypes are expected to be available from this. customer for their 800V AI data center and energy grid end-customers in. -- Delivered a second shipment of next generation B-TRAN custom packaged. samples and development kits for evaluation to Stellantis for EV. applications. We are working closely with Stellantis on a detailed. analysis of their solid-state contactor system-level specification to. optimize the solution and align the remaining deliverables under the. -- Entered into a long-term supply agreement with a high-volume wafer. foundry in Asia and achieved functional B-TRAN first silicon. This. foundry has ample capacity to support high-volume industrial and. automotive customers at a cost we believe will support our targeted gross. -- Seeing accelerating demand to support 800-volt DC architectures with a. growing numb","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2322448957.HKD","SGXZ99366536.SGD","BK4232","IE0031619046.USD","LU0266013472.USD","LU1992135472.HKD","IE00B19Z4B17.USD","LU2211815571.USD","LU2357305700.SGD","LU1548497426.USD","BK4096","LU2272731600.USD","BK4157","LUMA","LU2272731865.HKD","BK4585","BERZ","SGXZ81514606.USD","IE00B7SZL793.SGD","LU2931357623.SGD","LU1861220033.SGD","COHR","BK4141","LU2089985449.USD","LU2360107168.USD","COHX","COHC","COHH","LU2272731782.SGD","R","FWD","LU2473716301.USD","IPWR","IE00B66KJ199.SGD","SGXZ51526630.SGD","LU1720051017.SGD","LU1861215975.USD","LU1992135399.USD","BK4022","LU2322448791.USD","LU1720051108.HKD","SPRX","FOTO","LU2290526834.HKD","BK4148","EGGY","LU0274383776.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152838","title":"Press Release: Dogwood Therapeutics Announces Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152838","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659152838?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:30","pubTimestamp":1786624200,"startTime":"0","endTime":"0","summary":"2b Chemotherapy Induced Neuropathic Pain  study, with top-line. results readout expected in the fall of 2026.-- SP16 granted IND approval from the FDA. Study to begin enrolling in the. second-half of 2026 for the treatment of chemotherapy induced pain and. peripheral neuropathy . The study is fully funded by the. National Cancer Institute and will be conducted at the University of. -- Dogwood commences Phase 2b long-term extension study to assess. Halneuron's reduction in pain over three months of treatment. Patients. completing the ongoing Halneuron 4-week CINP Phase 2b study are now. eligible to enroll in the new 12-week open-label follow-on trial.-- The Company appointed Iain Dukes, D.Phil., Venture Partner at OrbiMed, as. -- Cash on hand of $9.6 million provides operational runway through the. Phase 2b readout in the fourth quarter of 2026.Second Quarter 2026 Financial ResultsResearch and development expenses for the second quarter of 2026 were $3.2 million, compared to $2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXG","LATR","VFH","LU1236620750.USD","LU0868494708.USD","FNCL","LU1645745479.HKD","LU1400636657.SGD","LU1670756490.USD","LU1861217088.USD","IE000BZT7R73.USD","LU2764263039.SGD","LU2404859741.USD","LU1228905037.USD","IPAY","LU1979441026.SGD","LU1917777945.USD","LU1814569148.SGD","IYG","LU0256863902.USD","TRUF","FDFF","LU0029864427.USD","LU0823434740.USD","LU1280957306.USD","V","LU0348723411.USD","LU2265009873.SGD","IE0000B7K699.USD","SG9999018865.SGD","LU0345774391.USD","TFNS","UYG","LENZ","LU0158827781.USD","DWTX","LU1121112475.USD","LU2023250504.SGD","LU2125909593.SGD","LU0689626769.HKD","LU2089284900.SGD","R","XLF","LU0390134368.USD","LU0106261372.USD","IE00B1XK9C88.USD","LU1037948541.HKD","LU1400636491.USD","LU2506952097.USD","IE00B19Z8X17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659200151","title":"Press Release: Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659200151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659200151?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622400,"startTime":"0","endTime":"0","summary":"-- Processed 2,770 EsoGuard Esophageal DNA Tests in 2Q26.-- Secured a commercial coverage policy for EsoGuard from Concert, a. healthcare technology company recently acquired by Lyric that establishes. laboratory testing policies its client health plans can adopt. The policy. recognizes EsoGuard as medically necessary for patients meeting. established screening criteria and has already been adopted by multiple. -- Developed a health economic cost-effectiveness model evaluating EsoGuard. screening to support commercial payor engagement and coverage decisions,with preliminary results demonstrating improved clinical outcomes and. $1.5 million. Operating expenses were approximately $14.3 million, which","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","LCDL","BK4555","LCID","PAVM","BK4551","BK4596","BK4082","LCIZ","BK4099","R","BK4022","LUCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159750","title":"Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159750","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159750?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620600,"startTime":"0","endTime":"0","summary":"Second quarter 2026 net product revenue of $18.6 million; cash and cash equivalents of $219.1 million as of June 30, 2026LOTIS-7, LOTIS-5 and MZL IIT data submitted for presentation at ASHCompany eval","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4109","BK4022","BK4585","BK4232","BK4588","R","ASH","LENZ","ADC","ADCT","BK4080","BK4505","PFS","BK4007","BK4539","LABU","BK4195","LU2463526074.USD","BK4211","BK4139","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659597631","title":"Press Release: Defsec Technologies Inc. Announces Third Quarter Fiscal 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659597631","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659597631?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:29","pubTimestamp":1786620540,"startTime":"0","endTime":"0","summary":"-- Revenue from digitization services on Government programs up 121% from Q3. Fiscal 2025, with total revenue up 92% over the same period;-- Gross margin $ increase of 126%, with improvement in gross margin to. -- Strong cash and AR position of +$5.8 million; and. -- Test and Evaluation of BLISS completed with U.S. Army Vehicle Program. and invitation to an additional invitation-only U.S. Army-Hosted","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4604","DFSCW","BK4588","R","03160","BK4232","BK4022","BK4555","DFSC","BK4585","TM","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659506159","title":"Press Release: McGraw Hill, Inc. Reports Strong Fiscal First Quarter 2027 Results Exceeding Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2659506159","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659506159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:23","pubTimestamp":1786620180,"startTime":"0","endTime":"0","summary":"Enters Peak Selling Season With Momentum Amid Growing Revenue, Re-Occurring Revenue and Digital Revenue While Expanding Margins and Net IncomeCOLUMBUS, Ohio----August 13, 2026--McGraw Hill, Inc.  , a leading global provider of education solutions for preK-12, higher education and professional learning, today announced financial results for the fiscal first quarter 2027 ended June 30, 2026.Key Fiscal First Quarter 2027 Financial Highlights--  Total revenue of $549.9 million, an increase of 2.6% year-over-year,driven by strong execution in Higher Education and K-12 segments.--  Digital revenue of $353.5 million, an increase of 8.8% year-over-year,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","BK4204","BK4232","MH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659697156","title":"Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659697156","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659697156?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"Medical Oncology","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4605","ACP","LU2298322129.HKD","LU1854104046.USD","BK4139","IE00BZ199S13.USD","LU1854103824.USD","LU1861215975.USD","LU1720051108.HKD","TM","BK4604","LU1548497426.USD","IE00BD6J9T35.USD","LU0456854461.SGD","LU0724618433.USD","LU1983260115.SGD","LU2357305700.SGD","BK4006","BK4099","LU2360107325.USD","IE00BFMHRM44.USD","LU1720051017.SGD","BK4141","BK4232","LU1978683503.SGD","BK4585","BK4022","COAL","LU1861214812.USD","BK4555","LU1861220033.SGD","LU0348723411.USD","BK4187","BK4213","CRC","BETA","03160","LU0124384867.USD","LU0266512127.USD","BK4588","ON","R","PBLS","HCC","LU1861219969.SGD","BK4512"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}